Диссертация (1144259), страница 26

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 26)

H., Chen L., Yu W. F., Chen L. Sigma-1 receptorknockout impairs neurogenesis in dentate gyrus of adult hippocampus via downregulation of NMDA receptors // CNS Neurosci Ther. -- 2013. -- Sep. -- T. 19, № 9. -C. 705-13.[136] Tsai S. Y., Hayashi T., Harvey B. K., Wang Y., Wu W. W., Shen R. F., Zhang Y.,Becker K. G., Hoffer B. J., Su T. P. Sigma-1 receptors regulate hippocampal dendriticspine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway //Proc Natl Acad Sci U S A. -- 2009.

-- Dec 29. -- T. 106, № 52. -- C. 22468-73.[137] Vagnerova K., Hurn P. D., Bhardwaj A., Kirsch J. R. Sigma 1 receptor agonistsact as neuroprotective drugs through inhibition of inducible nitric oxide synthase //Anesth Analg. -- 2006. -- Aug. -- T. 103, № 2. -- C. 430-4, table of contents.[138] Ruscher K., Inacio A. R., Valind K., Rowshan Ravan A., Kuric E., Wieloch T.Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydro-chloride on inflammation after stroke // PLoS One.

-- 2012. -- T. 7,№ 9. -- C. e45118.[139] Allahtavakoli M., Jarrott B. Sigma-1 receptor ligand PRE-084 reduced infarctvolume, neurological deficits, pro-inflammatory cytokines and enhanced antiinflammatory cytokines after embolic stroke in rats // Brain Res Bull. -- 2011. -- May30. -- T. 85, № 3-4. -- C. 219-24.- 137 -[140] Lysko P. G., Gagnon R. C., Yue T. L., Gu J.

L., Feuerstein G. Neuroprotectiveeffects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brainischemia // Stroke. -- 1992. -- Mar. -- T. 23, № 3. -- C. 414-9.[141] Hall H., Iulita M. F., Gubert P., Flores Aguilar L., Ducatenzeiler A., Fisher A.,Cuello A. C. AF710B, an M1/sigma-1 receptor agonist with long-lasting diseasemodifying properties in a transgenic rat model of Alzheimer's disease // AlzheimersDement. -- 2017. -- Dec 29.[142] Villard V., Espallergues J., Keller E., Alkam T., Nitta A., Yamada K., NabeshimaT., Vamvakides A., Maurice T. Antiamnesic and neuroprotective effects of theaminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-inducedtoxicity in mice // Neuropsychopharmacology.

-- 2009. -- May. -- T. 34, № 6. -- C.1552-66.[143] Meunier J., Ieni J., Maurice T. The anti-amnesic and neuroprotective effects ofdonepezil against amyloid beta25-35 peptide-induced toxicity in mice involve aninteraction with the sigma1 receptor // Br J Pharmacol. -- 2006. -- Dec. -- T. 149, № 8. - C. 998-1012.[144] Maurice T., Su T. P., Privat A. Sigma1 (sigma 1) receptor agonists andneurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through acommon mechanism // Neuroscience. -- 1998. -- Mar.

-- T. 83, № 2. -- C. 413-28.[145] Ryskamp D., Wu J., Geva M., Kusko R., Grossman I., Hayden M., BezprozvannyI. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse modelof Huntington disease // Neurobiol Dis. -- 2017. -- Jan. -- T.

97, № Pt A. -- C. 46-59.[146] Bol'shakova A. V., Kraskovskaya N. A., Gainullina A. N., Kukanova E. O.,Vlasova O. L., Bezprozvanny I. B. Neuroprotective Effect of sigma1-Receptors on theCell Model of Huntington's Disease // Bull Exp Biol Med. -- 2017. -- Dec. -- T. 164, №2. -- C. 252-258.[147] Francardo V., Bez F., Wieloch T., Nissbrandt H., Ruscher K., Cenci M. A.Pharmacological stimulation of sigma-1 receptors has neurorestorative effects inexperimental parkinsonism // Brain.

-- 2014. -- Jul. -- T. 137, № Pt 7. -- C. 1998-2014.[148] Mancuso R., Olivan S., Rando A., Casas C., Osta R., Navarro X. Sigma-1Ragonist improves motor function and motoneuron survival in ALS mice //Neurotherapeutics. -- 2012. -- Oct. -- T. 9, № 4. -- C. 814-26.[149] Peviani M., Salvaneschi E., Bontempi L., Petese A., Manzo A., Rossi D.,Salmona M., Collina S., Bigini P., Curti D.

Neuroprotective effects of the Sigma-1receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linkedto SOD1 mutation // Neurobiol Dis. -- 2014. -- Feb. -- T. 62. -- C. 218-32.[150] Balasuriya D., D'Sa L., Talker R., Dupuis E., Maurin F., Martin P., Borgese F.,Soriani O., Edwardson J. M. A direct interaction between the sigma-1 receptor and thehERG voltage-gated K+ channel revealed by atomic force microscopy andhomogeneous time-resolved fluorescence (HTRF(R)) // J Biol Chem.

-- 2014. -- Nov14. -- T. 289, № 46. -- C. 32353-63.[151] Aydar E., Palmer C. P., Klyachko V. A., Jackson M. B. The sigma receptor as aligand-regulated auxiliary potassium channel subunit // Neuron. -- 2002. -- Apr 25. -- T.34, № 3. -- C. 399-410.- 138 -[152] Zhang K., Zhao Z., Lan L., Wei X., Wang L., Liu X., Yan H., Zheng J. Sigma-1Receptor Plays a Negative Modulation on N-type Calcium Channel // Front Pharmacol.-- 2017. -- T. 8. -- C.

302.[153] Soriani O., Rapetti-Mauss R. Sigma 1 Receptor and Ion Channel Dynamics inCancer // Adv Exp Med Biol. -- 2017. -- T. 964. -- C. 63-77.[154] Schmidt H. R., Zheng S., Gurpinar E., Koehl A., Manglik A., Kruse A. C. Crystalstructure of the human sigma1 receptor // Nature. -- 2016. -- Apr 28.

-- T. 532, № 7600.-- C. 527-30.[155] Sharma P., Ignatchenko V., Grace K., Ursprung C., Kislinger T., Gramolini A. O.Endoplasmic reticulum protein targeting of phospholamban: a common role for an Nterminal di-arginine motif in ER retention? // PLoS One. -- 2010. -- Jul 9.

-- T. 5, № 7. - C. e11496.[156] Hanner M., Moebius F. F., Flandorfer A., Knaus H. G., Striessnig J., Kempner E.,Glossmann H. Purification, molecular cloning, and expression of the mammaliansigma1-binding site // Proc Natl Acad Sci U S A. -- 1996. -- Jul 23. -- T. 93, № 15. -- C.8072-7.[157] Mavylutov T., Chen X., Guo L., Yang J. APEX2- tagging of Sigma 1-receptorindicates subcellular protein topology with cytosolic N-terminus and ER luminal Cterminus // Protein Cell. -- 2017.

-- Sep 19.[158] Mishra A. K., Mavlyutov T., Singh D. R., Biener G., Yang J., Oliver J. A., RuohoA., Raicu V. The sigma-1 receptors are present in monomeric and oligomeric forms inliving cells in the presence and absence of ligands // Biochem J. -- 2015. -- Mar 1. -- T.466, № 2. -- C. 263-71.[159] Gromek K. A., Suchy F. P., Meddaugh H.

R., Wrobel R. L., LaPointe L. M., ChuU. B., Primm J. G., Ruoho A. E., Senes A., Fox B. G. The oligomeric states of thepurified sigma-1 receptor are stabilized by ligands // J Biol Chem. -- 2014. -- Jul 18. -T. 289, № 29. -- C. 20333-44.[160] Pal A., Hajipour A. R., Fontanilla D., Ramachandran S., Chu U. B., MavlyutovT., Ruoho A. E. Identification of regions of the sigma-1 receptor ligand binding siteusing a novel photoprobe // Mol Pharmacol. -- 2007. -- Oct.

-- T. 72, № 4. -- C. 921-33.[161] Chu U. B., Ramachandran S., Hajipour A. R., Ruoho A. E. Photoaffinity labelingof the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence ofreceptor dimers // Biochemistry. -- 2013. -- Feb 5. -- T. 52, № 5. -- C. 859-68.[162] Tsai S.

A., Su T. P. Sigma-1 Receptors Fine-Tune the Neuronal Networks // AdvExp Med Biol. -- 2017. -- T. 964. -- C. 79-83.[163] Kinoshita M., Matsuoka Y., Suzuki T., Mirrielees J., Yang J. Sigma-1 receptoralters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity toreceptor ligands // Brain Res. -- 2012. -- May 3.

-- T. 1452. -- C. 1-9.[164] van Meer G., Voelker D. R., Feigenson G. W. Membrane lipids: where they areand how they behave // Nat Rev Mol Cell Biol. -- 2008. -- Feb. -- T. 9, № 2. -- C. 11224.[165] Juhasz J., Davis J. H., Sharom F. J. Fluorescent probe partitioning in giantunilamellar vesicles of 'lipid raft' mixtures // Biochem J. -- 2010. -- Sep 15.

-- T. 430, №3. -- C. 415-23.- 139 -[166] Wesolowska O., Michalak K., Maniewska J., Hendrich A. B. Giant unilamellarvesicles - a perfect tool to visualize phase separation and lipid rafts in model systems //Acta Biochim Pol. -- 2009. -- T. 56, № 1. -- C. 33-9.[167] Veatch S. L., Keller S. L. Miscibility phase diagrams of giant vesicles containingsphingomyelin // Phys Rev Lett. -- 2005. -- Apr 15. -- T. 94, № 14.

-- C. 148101.[168] Veatch S. L., Keller S. L. Separation of liquid phases in giant vesicles of ternarymixtures of phospholipids and cholesterol // Biophys J. -- 2003. -- Nov. -- T. 85, № 5. -C. 3074-83.[169] Baumgart T., Hammond A. T., Sengupta P., Hess S.

T., Holowka D. A., Baird B.A., Webb W. W. Large-scale fluid/fluid phase separation of proteins and lipids in giantplasma membrane vesicles // Proc Natl Acad Sci U S A. -- 2007. -- Feb 27. -- T. 104, №9. -- C. 3165-70.[170] Sezgin E., Kaiser H. J., Baumgart T., Schwille P., Simons K., Levental I.Elucidating membrane structure and protein behavior using giant plasma membranevesicles // Nat Protoc. -- 2012. -- May 3. -- T.

Характеристики

Список файлов диссертации